Effect of dynamic circulating tumor DNA minimal residual disease detection on recurrence surveillance and second resection rate after curative intent resection of colorectal liver metastasis: A prospective cohort study.

被引:0
|
作者
Li, Yaqi
Xu, Jing
Chen, Yikuan
Ma, Xiaoji
Hu, Xiang
Chen, Yun
Sun, Lei
Wu, Huizi
Xiu, Zhihui
Dong, Qiduo
Chen, Lin
Liu, Jun
Cai, Sanjun
Peng, Junjie
机构
[1] Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai, Peoples R China
[2] BGI Genom, Shenzhen, Peoples R China
[3] Tianjin Med Lab BGI, Tianjin, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
242
引用
收藏
页码:242 / 242
页数:1
相关论文
共 24 条
  • [1] Personalized circulating tumor DNA monitoring improves recurrence surveillance and management after curative resection of colorectal liver metastases: a prospective cohort study
    Li, Yaqi
    Xu, Jing
    Hu, Xiang
    Chen, Yikuan
    Liu, Fangqi
    Chen, Yun
    Ma, Xiaoji
    Dong, Qiduo
    Sun, Lei
    Mo, Shaobo
    Zhang, Long
    He, Xingfeng
    Tong, Shanyou
    Wu, Huizi
    Li, Wenhua
    Cai, Sanjun
    Zhu, Shida
    Pan, Qi
    Peng, Junjie
    INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (05) : 2776 - 2787
  • [2] Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study
    Tie, Jeanne
    Wang, Yuxuan
    Cohen, Joshua
    Li, Lu
    Hong, Wei
    Christie, Michael
    Wong, Hui Li
    Kosmider, Suzanne
    Wong, Rachel
    Thomson, Benjamin
    Choi, Julian
    Fox, Adrian
    Field, Kathryn
    Burge, Matthew
    Shannon, Jenny
    Kotasek, Dusan
    Tebbutt, Niall C.
    Karapetis, Christos
    Underhill, Craig
    Haydon, Andrew
    Schaeffer, Joy
    Ptak, Janine
    Tomasetti, Cristian
    Papadopoulos, Nicholas
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Gibbs, Peter
    PLOS MEDICINE, 2021, 18 (05)
  • [3] Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases
    Marmorino, Federica
    Prisciandaro, Michele
    Giordano, Mirella
    Ortolan, Elisa
    Crucitta, Stefania
    Manca, Paolo
    Antoniotti, Carlotta
    Valenti, Marta Maria
    Danesi, Romano
    Conca, Veronica
    Mazzoli, Giacomo
    Boccaccino, Alessandra
    Carullo, Martina
    Martinetti, Antonia
    Sottotetti, Elisa
    Masi, Gianluca
    Sposito, Carlo
    Zaffaroni, Nadia
    Milione, Massimo
    Fontanini, Gabriella
    Del Re, Marzia
    Pietrantonio, Filippo
    Cremolini, Chiara
    JCO PRECISION ONCOLOGY, 2022, 6
  • [4] Circulating tumor DNA for prognosis assessment and postoperative management after curative-intent resection of colorectal liver metastases
    Reinert, Thomas
    Petersen, Lena Marie Skindhoj
    Henriksen, Tenna Vesterman
    Larsen, Marie Obo
    Rasmussen, Mads Heilskov
    Johansen, Amanda Frydendahl Boll
    Ogaard, Nadia
    Knudsen, Michael
    Nordentoft, Iver
    Vang, Soren
    Krag, Soren Rasmus Palmelund
    Knudsen, Anders Riegels
    Mortensen, Frank Viborg
    Andersen, Claus Lindbjerg
    INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (09) : 1537 - 1548
  • [5] Tumour-agnostic circulating tumour DNA analysis for improved recurrence surveillance after resection of colorectal liver metastases: A prospective cohort study
    Ogaard, Nadia
    Reinert, Thomas
    Henriksen, Tenna, V
    Frydendahl, Amanda
    Aagaard, Emilie
    Orntoft, Mai-Britt W.
    Larsen, Marie O.
    Knudsen, Anders R.
    Mortensen, Frank, V
    Andersen, Claus L.
    EUROPEAN JOURNAL OF CANCER, 2022, 163 : 163 - 176
  • [6] Circulating metabolites as a concept beyond tumor biology determining disease recurrence after resection of colorectal liver metastasis
    Jonas, Jan P.
    Hackl, Hubert
    Pereyra, David
    Santol, Jonas
    Ortmayr, Gregor
    Rumpf, Benedikt
    Najarnia, Sina
    Schauer, Dominic
    Brostjan, Christine
    Gruenberger, Thomas
    Starlinger, Patrick
    HPB, 2022, 24 (01) : 116 - 129
  • [7] Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis
    Chidharla, Anusha
    Rapoport, Eliot
    Agarwal, Kriti
    Madala, Samragnyi
    Linares, Brenda
    Sun, Weijing
    Chakrabarti, Sakti
    Kasi, Anup
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (12)
  • [8] Circulating tumor DNA (ctDNA) as a minimal residual disease (MRD) assessment and recurrence risk in patients undergoing curative intent resection with or without adjuvant chemotherapy in colorectal cancer: A systematic review and meta-analysis.
    Chidharla, Anusha
    Rapoport, Eliot
    Agarwal, Kriti
    Linares, Brenda
    Chakrabarti, Sakti
    Kasi, Anup
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] Non-invasive minimal residual disease detection of liver cancer using circulating tumor DNA features and α-fetoprotein: A prospective study.
    Chang, Yinyin
    Ren, Qingqi
    Li, Shiyong
    Zhang, Liangliang
    Feng, Yumin
    Long, Guanghui
    Mao, Mao
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (23_SUPPL) : 229 - 229
  • [10] Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment
    Parikh, Aparna R.
    Chee, Bryant H.
    Tsai, Jill
    Rich, Thereasa A.
    Price, Kristin S.
    Patel, Sonia A.
    Zhang, Li
    Ibrahim, Faaiz
    Esquivel, Mikaela
    Van Seventer, Emily E.
    Jarnagin, Joy X.
    Raymond, Victoria M.
    Corvera, Carlos U.
    Hirose, Kenzo
    Nakakura, Eric K.
    Corcoran, Ryan B.
    Van Loon, Katherine
    Atreya, Chloe E.
    CLINICAL CANCER RESEARCH, 2024, 30 (14) : 2964 - 2973